克利夫兰临床研究人员发现了一种新的细菌,即托马西拉免疫杆菌,它分解了SIGA,并可能导致肠道炎病。 Cleveland Clinic researchers discovered a new bacterium, Tomasiella immunophila, that breaks down SIgA and may contribute to inflammatory bowel diseases.

克利夫兰临床研究人员发现了一种新的细菌托马西拉免疫杆菌,它破坏了肠道免疫力,并可能助长炎症肠病、克罗恩氏病和溃疡性脊髓炎等疾病。 Cleveland Clinic researchers have identified a new bacterium, Tomasiella immunophila, which undermines gut immunity and may contribute to conditions like inflammatory bowel disease, Crohn's, and ulcerative colitis. 这种细菌分解了秘密免疫球球A(SIGA),这是肠道免疫防御的重要成分。 This bacterium breaks down secretory immunoglobulin A (SIgA), a vital component of the gut's immune defense. 这一发现为潜在的新疗法铺平了道路,这些疗法旨在恢复SIGA水平和改善肠胃健康。 The discovery paves the way for potential new therapies aimed at restoring SIgA levels and improving gut health.